Trial
NCT04763564
Efficacy of Liraglutide Therapy in Patients With IPAA
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Novo Nordisk A/S
Condition
Pouchitis
Intervention
Liraglutide Pen Injector
Why stopped
Due to an interruption in drug supply, the study was terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-23